• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BJOG: an international journal of obstetrics and gynaecology >Advances in the medical management of endometriosis
【24h】

Advances in the medical management of endometriosis

机译：子宫内膜异位症的医学管理进展

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The aim of medical therapy for endometriosis is to relieve pain and bleeding. Medical therapy for endometriosis is rarely offered to women wishing to conceive because treatment may further compromise fertility in these women. As the disease is chronic and often relapses, long term or repeated courses of treatment may be required. Efficacy is highest during therapy, with recurrence of symptoms during treatment-free intervals. However, the efficacy of different medical therapies has not been adequately compared and their adverse effect profiles vary enormously. In view of this, therapy should be individualised according to the severity of the disease and the wishes of each women. As our understanding of the pathophysiology of endometriosis has improved, it has been possible to make advances in medical intervention. Newer, chemotherapeutic approaches specifically target endometriotic deposits to minimise systemic adverse effects, such as menstrual cycle suppression, typical of traditional treatments.
机译：子宫内膜异位症的药物治疗的目的是减轻疼痛和出血。很少为希望怀孕的妇女提供子宫内膜异位症的药物治疗，因为治疗可能会进一步损害这些妇女的生育能力。由于该疾病是慢性疾病且经常复发，因此可能需要长期或反复的治疗过程。治疗期间疗效最高，无治疗间隔期间症状复发。但是，不同的药物疗法的疗效尚未得到充分的比较，其不良反应也相差很大。有鉴于此，应根据疾病的严重程度和每个妇女的意愿进行个性化治疗。随着我们对子宫内膜异位症的病理生理学的认识得到提高，在医学干预方面取得了进展。较新的化学疗法专门针对子宫内膜异位症的沉积物，以最大程度地减少全身性不良反应，例如传统疗法中常见的月经周期抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号